Medipal Holdings Corp

Medipal Holdings Corp

  • Price (EUR)14.70
  • Today's Change0.10 / 0.68%
  • Shares traded0.00
  • 1 Year change+19.51%
  • Beta--
Data delayed at least 15 minutes, as of Jun 02 2023 16:16 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

MEDIPAL HOLDINGS CORPORATION engages in the wholesale of pharmaceutical products, cosmetics and daily miscellaneous goods. The Company operates in three segments. The Ethical Pharmaceutical Wholesale segment is involved in the wholesale of pharmaceutical products, medical equipment and test reagents, the distribution and planning of specialty drugs, the construction of medical material database and others. The Cosmetics, Daily Product and General Medicine Wholesale segment is engaged in the wholesale of cosmetics, daily miscellaneous goods and general pharmaceuticals. The Veterinary Medicine and Food Processing Raw Materials Wholesale segment is engaged in the wholesale of veterinary products, food additives and food raw materials. The Company is also involved in the provision of cleaning services, the management and operation of logistics centers, the provision of manpower dispatching services and others.

  • Revenue in JPY (TTM)3.36tn
  • Net income in JPY38.81bn
  • Incorporated1923
  • Employees12.80k
  • Location
    Medipal Holdings Corp2-7-15, YaesuCHUO-KU 104-8461JapanJPN
  • Phone+81 335175800
  • Fax+81 335175028
  • Websitehttps://www.medipal.co.jp/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
7459:TYO since
Sumitomo Pharma Food & Chemical Co LtdDeal completed30 Nov 202230 Nov 2022Deal completed20.99%313.47m
Toshichi IncDeal completed29 Jul 202229 Jul 2022Deal completed8.62%56.26m
Data delayed at least 20 minutes, as of Jun 02 2023 07:00 BST.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.